Category IP-Watch Briefs

Crowdfunded Contest: What Should Future Of Copyright Law Look Like?

The Modern Poland Foundation, a non-profit and access to knowledge advocate, is asking people around the globe to participate in a crowdfunded contest that poses the question: What should a good copyright system look like?

MSF: Prices On Latest ARV Drugs Under Patent Too High

The price of first- and second-line anti-retrovirals (ARVs) have declined due to increased generic competition, while third-line regimens remain “exorbitantly priced,” according to the latest edition of a publication from Médecins Sans Frontières (MSF).

Medicines Patent Pool Signs New Licence Agreements

The Medicines Patent Pool, Shilpa Medicare, and Gilead Sciences have signed an agreement to increase access to HIV treatment medicines. The agreement will allow Shilpa Medicare to manufacture “five key HIV medicines for sale in 100-112 countries,” and the goal is to cover “a majority of people living with HIV.”

Infojustice.org: UN Consumer Guidelines Could Be Updated For Digital Rights, A2K

Infojustice.org reports: "Over the last three years a global network of consumer activists has been crafting a set of amendments to an influential global instrument, the United Nations Guidelines for Consumer Protection, that could provide a powerful global standard for digital rights and access to knowledge. UNCTAD agreed to their review and set a date – July 11 and 12 – at which to consider proposed amendments."

Publishers Urge European Commission To Reject Google’s Competition Proposal

Hundreds of European publishers have issued a call for the European Commission to reject draft remedies put forward by Google to settle concerns about market dominance in web searching and search advertising.

UNAIDS Reports Sharp Drop In New HIV Infections In Some African Countries

Since 2009, seven countries in sub-Saharan Africa have reduced new HIV infections among children by 50 percent, and others have made significant progress, according to a new report by UNAIDS. But efforts in some countries have stalled, it said.

US Gives Boost To Materials Genome Initiative

The Obama administration and academic and industry partners today announced their commitment to support the Materials Genome Initiative (MGI), a public-private endeavor whose aim is to reduce the time required to develop novel materials that can “fuel advanced manufacturing and bolster the 21st century American economy.”